Changes to the Code
S. 4989 · Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 288 Ruth L. Kirschstein National Research Service Awards
1 change the bill asks for here, 1 carried out
- Carried out:
Section 487(a) of the Public Health Service Act (42 U.S.C. 288(a)) is amended by adding at the end the following:
(5) For purposes of the program under this subsection, biomedical and behavioral research includes diagnostic safety and quality research..
§ 288(a)–(b)
Start of § 288 to (a)(2) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (a)(3) | (3) | (3) | ||
| In awarding Ruth L. Kirschstein National Research Service Awards under this section, the Secretary shall take account of the Nation’s overall need for biomedical research personnel by giving special consideration to physicians who agree to undertake a minimum of two years of biomedical research. | In awarding Ruth L. Kirschstein National Research Service Awards under this section, the Secretary shall take account of the Nation’s overall need for biomedical research personnel by giving special consideration to physicians who agree to undertake a minimum of two years of biomedical research. | |||
| (a)(4) | (4) | (4) | ||
| The Secretary shall carry out paragraph (1) in a manner that will result in the recruitment of women, and individuals from disadvantaged backgrounds (including racial and ethnic minorities), into fields of biomedical or behavioral research and in the provision of research training to women and such individuals. | The Secretary shall carry out paragraph (1) in a manner that will result in the recruitment of women, and individuals from disadvantaged backgrounds (including racial and ethnic minorities), into fields of biomedical or behavioral research and in the provision of research training to women and such individuals. | |||
| (a)(5) | (5) [inserted: ] | |||
| [inserted: For purposes of the program under this subsection, biomedical and behavioral research includes diagnostic safety and quality research.] | ||||
| (b) | (b) Prerequisites for Award; review and approval by appropriate advisory councils; Award period; uses for Award; payments to non-Federal public or nonprofit private institutions | (b) Prerequisites for Award; review and approval by appropriate advisory councils; Award period; uses for Award; payments to non-Federal public or nonprofit private institutions | ||
| (b)(1) | (1) | (1) | ||
| No Ruth L. Kirschstein National Research Service Award may be made by the Secretary to any individual unless— | No Ruth L. Kirschstein National Research Service Award may be made by the Secretary to any individual unless— | |||
Rest of § 288 unchanged
42 U.S.C. § 299a General authorities
2 changes the bill asks for here, 2 carried out
- Carried out:
by inserting
and diagnostic safety and quality
aftersubsection (a)
; and - Carried out:
by striking
under section 487(d)(3)
and insertingfor purposes of carrying out section 487
.
§ 299a(a)–(c)
Start of § 299a to (a)(8) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (a)(9) | (9) | (9) | ||
| medical liability. | medical liability. | |||
| (b) | (b) Health services training grants | (b) Health services training grants | ||
| (b)(1) | (1) In general | (1) In general | ||
| The Director may provide training grants in the field of health services research related to activities authorized under subsection (a), to include pre- and post-doctoral fellowships and training programs, young investigator awards, and other programs and activities as appropriate. In carrying out this subsection, the Director shall make use of funds made available | The Director may provide training grants in the field of health services research related to activities authorized under subsection (a)[inserted: and diagnostic safety and quality], to include pre- and post-doctoral fellowships and training programs, young investigator awards, and other programs and activities as appropriate. In carrying out this subsection, the Director shall make use of funds made available [inserted: for] [inserted: purposes] of [inserted: carrying] [inserted: out] [inserted: section 487 ]as well as other appropriated funds. | |||
| (b)(2) | (2) Requirements | (2) Requirements | ||
| In developing priorities for the allocation of training funds under this subsection, the Director shall take into consideration shortages in the number of trained researchers who are addressing health care issues for the priority populations identified in section 299(c)(1)(B) of this title and in addition, shall take into consideration indications of long-term commitment, amongst applicants for training funds, to addressing health care needs of the priority populations. | In developing priorities for the allocation of training funds under this subsection, the Director shall take into consideration shortages in the number of trained researchers who are addressing health care issues for the priority populations identified in section 299(c)(1)(B) of this title and in addition, shall take into consideration indications of long-term commitment, amongst applicants for training funds, to addressing health care needs of the priority populations. | |||
| (c) | (c) Multidisciplinary centers | (c) Multidisciplinary centers | ||
| The Director may provide financial assistance to assist in meeting the costs of planning and establishing new centers, and operating existing and new centers, for multidisciplinary health services research, demonstration projects, evaluations, training, and policy analysis with respect to the matters referred to in subsection (a). | The Director may provide financial assistance to assist in meeting the costs of planning and establishing new centers, and operating existing and new centers, for multidisciplinary health services research, demonstration projects, evaluations, training, and policy analysis with respect to the matters referred to in subsection (a). |
Rest of § 299a unchanged
42 U.S.C. § 299b–31 Quality measure development
2 changes the bill asks for here, 2 carried out
- Carried out:
by redesignating subparagraphs (B) through (J) as subparagraphs (C) through (K), respectively; and
- Carried out:
by inserting after subparagraph (A) the following:
(B) diagnostic safety and quality;.
§ 299b–31(c)Grants or contracts for quality measure development(2)–(3)
Start of § 299b–31 to (c)(1) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (2) | (2) Prioritization in the development of quality measures | (2) Prioritization in the development of quality measures | ||
| In awarding grants, contracts, or agreements under this subsection, the Secretary shall give priority to the development of quality measures that allow the assessment of— | In awarding grants, contracts, or agreements under this subsection, the Secretary shall give priority to the development of quality measures that allow the assessment of— | |||
| (2)(A) | (A) | (A) | ||
| health outcomes and functional status of patients; | health outcomes and functional status of patients; | |||
| (2)(B) | (B) [inserted: ] | |||
| [inserted: diagnostic safety and quality;] | ||||
| (2)(C) | [inserted: (C)] | |||
| the management and coordination of health care across episodes of care and care transitions for patients across the continuum of providers, health care settings, and health plans; | the management and coordination of health care across episodes of care and care transitions for patients across the continuum of providers, health care settings, and health plans; | |||
| (2)(D) | [inserted: (D)] | |||
| the experience, quality, and use of information provided to and used by patients, caregivers, and authorized representatives to inform decisionmaking about treatment options, including the use of shared decisionmaking tools and preference sensitive care (as defined in section 299b–36 of this title); | the experience, quality, and use of information provided to and used by patients, caregivers, and authorized representatives to inform decisionmaking about treatment options, including the use of shared decisionmaking tools and preference sensitive care (as defined in section 299b–36 of this title); | |||
| (2)(E) | [inserted: (E)] | |||
| the meaningful use of health information technology; | the meaningful use of health information technology; | |||
| (2)(F) | [inserted: (F)] | |||
| the safety, effectiveness, patient-centeredness, appropriateness, and timeliness of care; | the safety, effectiveness, patient-centeredness, appropriateness, and timeliness of care; | |||
| (2)(G) | [inserted: (G)] | |||
| the efficiency of care; | the efficiency of care; | |||
| (2)(H) | [inserted: (H)] | |||
| the equity of health services and health disparities across health disparity populations (as defined in section 285t1 of this title) and geographic areas; | the equity of health services and health disparities across health disparity populations (as defined in section 285t1 of this title) and geographic areas; | |||
| (2)(I) | [inserted: (I)] | |||
| patient experience and satisfaction; | patient experience and satisfaction; | |||
| (2)(J) | [inserted: (J)] | |||
| the use of innovative strategies and methodologies identified under section 299b–33 of this title; and | the use of innovative strategies and methodologies identified under section 299b–33 of this title; and | |||
| (2)(K) | [inserted: (K)] | |||
| other areas determined appropriate by the Secretary. | other areas determined appropriate by the Secretary. | |||
| (3) | (3) Eligible entities | (3) Eligible entities | ||
| To be eligible for a grant or contract under this subsection, an entity shall— | To be eligible for a grant or contract under this subsection, an entity shall— | |||
| (3)(A) | (A) | (A) | ||
| have demonstrated expertise and capacity in the development and evaluation of quality measures; | have demonstrated expertise and capacity in the development and evaluation of quality measures; | |||
Rest of § 299b–31 unchanged